Amplified Sciences

Amplified Sciences is a molecular diagnostics company that develops ultra-sensitive molecular sensing technology exclusively licensed from Purdue University. Their first application is an assay for the early detection of pancreatic cancer, which they claim will quickly prove their investment thesis due to large unmet medical need and a favorable reimbursement path. The company has delivered a working prototype and published proof of concept data.

The company's technology is disease state agnostic and can detect to the single molecule level. It scales easily to point of care and provides a very favorable cost structure for their platform of reagents. This unique composition of matter IP is a key differentiator for their diagnostics platform.

Some reviewers praise the company for excellent product quality and top-notch customer service. They frequently mention that the company went above and beyond to resolve minor issues quickly, leaving customers extremely satisfied with their service.

All eight reviews on Trustburn are from 2023, with the most recent posted on November 6, 2023. The rating split shows six 5-star reviews, one 4-star review, and one 3-star review, resulting in an overall Trustburn rating of 4.3 out of 5.

News sources report that Amplified Sciences enrolls patients in the PanAMP real-world, multicenter clinical utility study. They also secured $2.6 million in seed funding from Elevate Ventures and received support from the AGA Fund for cyst care initiatives.

Reddit users have expressed interest in the company's SBIR/STTR Impact series, highlighting the power of federal funding. Some users found a deep dive into Amplified Sciences particularly compelling in discussions about federal funding programs.

The company's website, amplifiedsciences.com, is described as easy to navigate with a smooth purchasing process. Customers noted that the website was straightforward and the overall experience was positive.

Some reviewers mentioned that the product arrived quickly and was exactly as described. The shipping speed and accuracy of the product description were highlighted as positive aspects of the customer experience.

The technology is based on SERS (Surface-Enhanced Raman Scattering), which is described as bringing small signals to big impact in diagnostics. This approach allows for ultra-sensitive detection at the single molecule level.

The company is located in West Lafayette, IN, USA, as indicated by their job board listing. They are developing a portfolio of diagnostics solutions through this location.

The company has been active since at least 2021, when they were listed as one of the most fundable companies. They have since secured multiple funding rounds and initiated patient enrollment for clinical studies.

Some reviewers shared that they had a positive experience over a long period of using the products. They consistently found the quality great and the customer service outstanding throughout their time as customers.

The company's process involves delivering a working prototype and publishing proof of concept data before enrolling patients in clinical utility studies. This step-by-step approach validates their technology before broader deployment.

The company's technology is disease state agnostic, meaning it can be applied to various conditions. This flexibility allows them to focus initially on pancreatic cancer while maintaining a versatile platform.

You can reach Amplified Sciences by e-mail at contact@amplifiedsci.com.